A randomized, placebo controlled, double blinded, parallel group clinical study to evaluate the efficacy and safety of AEV01 along with standard care for elderly patients with mild COVID-19

A randomized, placebo controlled, double blinded, parallel group clinical study to evaluate the efficacy and safety of AEV01 along with standard care for elderly patients with mild COVID-19

Background: While several drugs are in the pipeline for treatment of various grades of COVID-19 disease, none of them have shown promise until now. Medicinal plants are crucial in developing and developed countries for their primary and basic health needs owing to better tolerability, superior compa...

Full description

Bibliographic Details
Main Authors: Aravinda Kumar Balan, Ramesh Kannan, Vanitha Muralikumar, Vamseedhar Annam, Sakthi Balan Murugesan, MM Sekhar, Renu Medasani
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Journal of Ayurveda and Integrative Medicine
Subjects:
COVID-19
Picrorhiza kurroa, AEV01
Ayurveda
Immunomodulatory
SARS-COV-2
Immunity.
Online Access:http://www.sciencedirect.com/science/article/pii/S0975947623001778

Similar Items

Similar Items